These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 5666014)

  • 1. Studies on the hypertensive response elicited by reserpine or tetrabenazine in rats treated with amphetamine-like drugs.
    Bonaccorsi A
    Eur J Pharmacol; 1968 May; 3(2):97-105. PubMed ID: 5666014
    [No Abstract]   [Full Text] [Related]  

  • 2. The relative effects of d-amphetamine, imipramine and harmaline on tetrabenazine suppression of schedule-controlled behavior in the rat.
    McKearney JW
    J Pharmacol Exp Ther; 1968 Feb; 159(2):429-40. PubMed ID: 5638662
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of desmethylimipramine, protriptyline and (+)-amphetamine on fluorescence of central adrenergic neurons of rats pretreated with alpha-methyl-DOPA and tetrabenazine or reserpine.
    Carlsson A; Fuxe K; Hökfelt T
    Eur J Pharmacol; 1967 Dec; 2(3):196-201. PubMed ID: 5590343
    [No Abstract]   [Full Text] [Related]  

  • 4. [Drugs with effect on the adrenergic nerve fiber].
    Haefely W
    Pharm Acta Helv; 1968 Dec; 43(12):757-75. PubMed ID: 4886667
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of antidepressant and adrenergic blocking drugs on hyperthermia induced by reserpine.
    Jori A; Paglialunga S; Garattini S
    Arch Int Pharmacodyn Ther; 1967 Feb; 165(2):384-93. PubMed ID: 4382965
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of central monoamines in decapitation convulsions of mice.
    Kamat UG; Sheth UK
    Neuropharmacology; 1971 Sep; 10(5):571-9. PubMed ID: 4399542
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of reserpine on body temperature in the rat after pretreatment with amphetamine and monoamineoxidase inhibitors.
    Cremades A; Serrano JS; Jané F; Milanés MV
    Methods Find Exp Clin Pharmacol; 1982; 4(8):563-8. PubMed ID: 7169843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of reserpine and prenylamine on the L-dopa turnover in the rat exocrine pancreas.
    Alm P; Ehinger B; Falck B; Nordgren L
    Eur J Pharmacol; 1971 Oct; 16(2):192-200. PubMed ID: 5161258
    [No Abstract]   [Full Text] [Related]  

  • 9. The interference of tetrabenazine, benzquinamide and prenylamine with the action of reserpine.
    Carlsson A; Lindqvist M
    Acta Pharmacol Toxicol (Copenh); 1966; 24(2):112-20. PubMed ID: 6013085
    [No Abstract]   [Full Text] [Related]  

  • 10. Investigations on the action and mechanism of action of diphenylhydantoin as an antagonist of tetrabenazine and reserpine.
    Lotti VJ; Torchiana L; Porter CC
    Arch Int Pharmacodyn Ther; 1973 May; 203(1):107-16. PubMed ID: 4125147
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of imipramine and related antidepressive drugs on estrus behaviour in ovariectomised rats activated by progesterone, reserpine or tetrabenazine in combination with estrogen.
    Meyerson BJ
    Acta Physiol Scand; 1966; 67(3):411-22. PubMed ID: 6007785
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of amphetamine on locomotion in mice pretreated with desmethylimipramine, tetrabenazine or both.
    Weissman A
    Psychopharmacologia; 1972; 23(2):152-9. PubMed ID: 5022607
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of the uptake of tritiated catecholamines by antidepressant and related agents.
    Ross SB; Renyi AL
    Eur J Pharmacol; 1967 Dec; 2(3):181-6. PubMed ID: 5591516
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro studies on central and peripheral monoamine neurons at the ultrastructural level.
    Hökfelt T
    Z Zellforsch Mikrosk Anat; 1968; 91(1):1-74. PubMed ID: 5724812
    [No Abstract]   [Full Text] [Related]  

  • 15. On the role of rate of brain norepinephrine release in the antibenzoquinolizine action of desipramine.
    Sulser F; Soroko F
    Psychopharmacologia; 1965 Sep; 8(3):191-200. PubMed ID: 5885875
    [No Abstract]   [Full Text] [Related]  

  • 16. The differential neurochemical bases of the behaviours elicited by serotonergic agents and by the combination of a monoamine oxidase inhibitor and L-DOPA.
    Deakin JF; Dashwood MR
    Neuropharmacology; 1981 Feb; 20(2):123-30. PubMed ID: 6451815
    [No Abstract]   [Full Text] [Related]  

  • 17. Potentiation of adrenergic cardiovascular effects of two quaternary nicotine analogues by reserpine.
    von Euler US; Persson NA
    Acta Physiol Scand; 1970 Apr; 78(4):459-64. PubMed ID: 5449085
    [No Abstract]   [Full Text] [Related]  

  • 18. Behavioral reactions to amphetamine in reserpinized rats.
    Morpurgo C; Theobald W
    Int J Neuropharmacol; 1966 Sep; 5(5):375-7. PubMed ID: 5970993
    [No Abstract]   [Full Text] [Related]  

  • 19. THE CUMULATIVE NATURE OF THE RESERPINE EFFECT AND THE POSSIBILITIES OF INHIBITING CUMULATION PHARMACOLOGICALLY.
    KNOLL J; KNOLL B
    Arch Int Pharmacodyn Ther; 1964 Mar; 148():200-16. PubMed ID: 14171749
    [No Abstract]   [Full Text] [Related]  

  • 20. A reappraisal of the interaction between tricyclic antidepressants and reserpine-like drugs.
    Willner P; Clark D
    Psychopharmacology (Berl); 1978 Jun; 58(1):55-62. PubMed ID: 97720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.